Volume 70, Issue 4, Pages (April 2019)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation.

Efficacy and Safety of Pemetrexed Maintenance Therapy versus Best Supportive Care in Patients from East Asia with Advanced, Nonsquamous Non-small Cell.

Volume 61, Issue 1, Pages (July 2014)

Volume 63, Issue 1, Pages (July 2015)

Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.

Volume 46, Issue 3, Pages (March 2007)

Inflammasomes in liver diseases

Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment Liver.

Radioembolization for hepatocellular carcinoma

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

The Impact of Body Mass Index Dynamics on Survival of Patients With Advanced Pancreatic Cancer Receiving Chemotherapy Younak Choi, MD, Tae-Yong Kim,

MP16-14 CLINICAL IMPLICATION OF METASTASECTOMY IN METACHRONOUS METASTATIC RENAL CELL CARCINOMA IN THE ERA OF TARGETED THERAPY Jong Won Kim, Jongsoo Lee,

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Volume 148, Issue 7, Pages e6 (June 2015)

Volume 68, Issue 5, Pages (May 2018)

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Hyoung Yoon Chang, MD, PhD, MPH, Dong In Suh, MD, Song-I

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery Jae-Kwan Song, MD, Mi-Jeong Kim, MD, Sung-Cheol Yun, PhD,

The rationality of N3 classification in the 7th edition of the International Union Against Cancer TNM staging system for gastric adenocarcinomas: A case-control.

Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)

Volume 93, Issue 4, Pages (April 2018)

The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors

Living donor liver transplantation: is the hype over?

Increased Copy Number of the Interleukin-6 Receptor Gene Is Associated with Adverse Survival in Multiple Myeloma Patients Treated with Autologous Stem.

Caffeine as an Adjuvant Therapy to Opioids in Cancer Pain: A Randomized, Double- Blind, Placebo-Controlled Trial Sang-Yeon Suh, MD, PhD, Youn Seon Choi,

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Jeeyun Lee, MD, Kyoung-Eun.

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell.

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

Volume 68, Issue 1, Pages (January 2018)

Seizure - European Journal of Epilepsy

First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status Young Joo Lee, MD, Heung Tae Kim, MD,

Targets for immunotherapy of liver cancer

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell.

Radioembolization for hepatocellular carcinoma

Volume 145, Issue 2, Pages (May 2017)

Volume 57, Issue 4, Pages (October 2012)

Fate of Functional Mitral Regurgitation and Predictors of Persistent Mitral Regurgitation After Isolated Aortic Valve Replacement Hyun-Chel Joo, MD,

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

EASL Clinical Practice Guidelines: Wilson’s disease

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin.

Wolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic

Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung.

Salvage Esophagectomy for Locoregional Failure After Chemoradiotherapy in Patients With Advanced Esophageal Cancer Changhoon Yoo, MD, Ji Hyun Park, MD,

Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III.

Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients.

Combined locoregional-immunotherapy for liver cancer

Volume 63, Issue 1, Pages (July 2015)

Volume 64, Issue 5, Pages (May 2016)

Volume 66, Issue 3, Pages (March 2017)

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Non– Small-Cell Lung Cancer Seung Jun Lee, MD, Jinwoo Lee, MD, Young.

New trials and results in systemic treatment of HCC

Pathogenesis of cholestatic hepatitis C

Josep M. Llovet, Robert Montal, Augusto Villanueva

Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung.

A Functional Polymorphism on Chromosome 15q25 Associated with Survival of Early Stage Non–Small-Cell Lung Cancer Guang Jin, MD, PhD, Eun Young Bae, BS,

Paradoxical psoriasis following anti–TNF therapy in ankylosing spondylitis: A population- based cohort study Jung Min Bae, MD, PhD, Hyuck Sun Kwon, MD,

Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell.

Partial hepatectomy vs

Presentation transcript:

Volume 70, Issue 4, Pages 684-691 (April 2019) Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial Joong-Won Park, Yoon Jun Kim, Do Young Kim, Si-Hyun Bae, Seung Woon Paik, Youn-Jae Lee, Hwi Young Kim, Han Chu Lee, Sang Young Han, Jae Youn Cheong, Oh Sang Kwon, Jong Eun Yeon, Bo Hyun Kim, Jaeseok Hwang Journal of Hepatology Volume 70, Issue 4, Pages 684-691 (April 2019) DOI: 10.1016/j.jhep.2018.11.029 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2019 70, 684-691DOI: (10. 1016/j. jhep. 2018. 11 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Consort flow diagram. cTACE, conventional transarterial chemoembolization. Journal of Hepatology 2019 70, 684-691DOI: (10.1016/j.jhep.2018.11.029) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Kaplan-Meier curves of overall survival, time to progression, and progression-free survival for the intention-to-treat population. HR, hazard ratio; OS, overall survival. Journal of Hepatology 2019 70, 684-691DOI: (10.1016/j.jhep.2018.11.029) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Forest plots showing subgroup analyses of overall survival. AFP, alpha-fetoprotein; cTACE, conventional transarterial chemoembolization; UICC, Union for International Cancer Control. Journal of Hepatology 2019 70, 684-691DOI: (10.1016/j.jhep.2018.11.029) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions